205 related articles for article (PubMed ID: 34502095)
1. A Dansyl-Modified Sphingosine Kinase Inhibitor DPF-543 Enhanced De Novo Ceramide Generation.
Shamshiddinova M; Gulyamov S; Kim HJ; Jung SH; Baek DJ; Lee YM
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502095
[TBL] [Abstract][Full Text] [Related]
2. Sphingosine kinase, sphingosine-1-phosphate, and apoptosis.
Maceyka M; Payne SG; Milstien S; Spiegel S
Biochim Biophys Acta; 2002 Dec; 1585(2-3):193-201. PubMed ID: 12531554
[TBL] [Abstract][Full Text] [Related]
3. Recycling of sphingosine is regulated by the concerted actions of sphingosine-1-phosphate phosphohydrolase 1 and sphingosine kinase 2.
Le Stunff H; Giussani P; Maceyka M; Lépine S; Milstien S; Spiegel S
J Biol Chem; 2007 Nov; 282(47):34372-80. PubMed ID: 17895250
[TBL] [Abstract][Full Text] [Related]
4. Regulation of de novo sphingolipid biosynthesis by the ORMDL proteins and sphingosine kinase-1.
Siow D; Sunkara M; Morris A; Wattenberg B
Adv Biol Regul; 2015 Jan; 57():42-54. PubMed ID: 25319495
[TBL] [Abstract][Full Text] [Related]
5. Drugging sphingosine kinases.
Santos WL; Lynch KR
ACS Chem Biol; 2015 Jan; 10(1):225-33. PubMed ID: 25384187
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and Biological Evaluation of BODIPY-PF-543.
Shrestha J; Hwang GT; Lee T; Kim SW; Oh YS; Kwon Y; Hong SW; Kim S; Seop Moon H; Baek DJ; Park EY
Molecules; 2019 Dec; 24(23):. PubMed ID: 31810327
[TBL] [Abstract][Full Text] [Related]
7. Activation of sphingosine kinase by tumor necrosis factor-alpha inhibits apoptosis in human endothelial cells.
Xia P; Wang L; Gamble JR; Vadas MA
J Biol Chem; 1999 Nov; 274(48):34499-505. PubMed ID: 10567432
[TBL] [Abstract][Full Text] [Related]
8. Modulation of cellular S1P levels with a novel, potent and specific inhibitor of sphingosine kinase-1.
Schnute ME; McReynolds MD; Kasten T; Yates M; Jerome G; Rains JW; Hall T; Chrencik J; Kraus M; Cronin CN; Saabye M; Highkin MK; Broadus R; Ogawa S; Cukyne K; Zawadzke LE; Peterkin V; Iyanar K; Scholten JA; Wendling J; Fujiwara H; Nemirovskiy O; Wittwer AJ; Nagiec MM
Biochem J; 2012 May; 444(1):79-88. PubMed ID: 22397330
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of dansyl labeled sphingosine kinase 1 inhibitor.
Park EY; Lee T; Oh YS; Lee JY; Shrestha J; Hong SW; Jin YJ; Jo G; Kim S; Hwang GT; Han DS; Baek DJ
Chem Phys Lipids; 2018 Sep; 215():29-33. PubMed ID: 30044952
[TBL] [Abstract][Full Text] [Related]
10. Building a better sphingosine kinase-1 inhibitor.
Lynch KR
Biochem J; 2012 May; 444(1):e1-2. PubMed ID: 22533672
[TBL] [Abstract][Full Text] [Related]
11. Importance of sphingosine kinase (SphK) as a target in developing cancer therapeutics and recent developments in the synthesis of novel SphK inhibitors.
Plano D; Amin S; Sharma AK
J Med Chem; 2014 Jul; 57(13):5509-24. PubMed ID: 24471412
[TBL] [Abstract][Full Text] [Related]
12. Effect of the sphingosine kinase 1 selective inhibitor, PF-543 on arterial and cardiac remodelling in a hypoxic model of pulmonary arterial hypertension.
MacRitchie N; Volpert G; Al Washih M; Watson DG; Futerman AH; Kennedy S; Pyne S; Pyne NJ
Cell Signal; 2016 Aug; 28(8):946-55. PubMed ID: 27063355
[TBL] [Abstract][Full Text] [Related]
13. Ginsenoside compound K inhibits angiogenesis via regulation of sphingosine kinase-1 in human umbilical vein endothelial cells.
Shin KO; Seo CH; Cho HH; Oh S; Hong SP; Yoo HS; Hong JT; Oh KW; Lee YM
Arch Pharm Res; 2014; 37(9):1183-92. PubMed ID: 24687256
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of dihydroceramide desaturase activity by the sphingosine kinase inhibitor SKI II.
Cingolani F; Casasampere M; Sanllehí P; Casas J; Bujons J; Fabrias G
J Lipid Res; 2014 Aug; 55(8):1711-20. PubMed ID: 24875537
[TBL] [Abstract][Full Text] [Related]
15. De novo biosynthesis of dihydrosphingosine-1-phosphate by sphingosine kinase 1 in mammalian cells.
Berdyshev EV; Gorshkova IA; Usatyuk P; Zhao Y; Saatian B; Hubbard W; Natarajan V
Cell Signal; 2006 Oct; 18(10):1779-92. PubMed ID: 16529909
[TBL] [Abstract][Full Text] [Related]
16. Disruption of sphingolipid metabolism augments ceramide-induced autophagy in preeclampsia.
Melland-Smith M; Ermini L; Chauvin S; Craig-Barnes H; Tagliaferro A; Todros T; Post M; Caniggia I
Autophagy; 2015 Apr; 11(4):653-69. PubMed ID: 25853898
[TBL] [Abstract][Full Text] [Related]
17. Sphingosine Kinase Inhibitors as Maintenance Therapy of Glioblastoma After Ceramide-Induced Response.
Sordillo LA; Sordillo PP; Helson L
Anticancer Res; 2016 May; 36(5):2085-95. PubMed ID: 27127108
[TBL] [Abstract][Full Text] [Related]
18. Sphingosine kinase and sphingosine-1-phosphate regulate epithelial cell architecture by the modulation of de novo sphingolipid synthesis.
Santacreu BJ; Pescio LG; Romero DJ; Corradi GR; Sterin-Speziale N; Favale NO
PLoS One; 2019; 14(3):e0213917. PubMed ID: 30897151
[TBL] [Abstract][Full Text] [Related]
19. Sphingolipid metabolism is a crucial determinant of cellular fate in nonstimulated proliferating Madin-Darby canine kidney (MDCK) cells.
Nieto FL; Pescio LG; Favale NO; Adamo AM; Sterin-Speziale NB
J Biol Chem; 2008 Sep; 283(37):25682-25691. PubMed ID: 18625703
[TBL] [Abstract][Full Text] [Related]
20. Structure guided design of a series of sphingosine kinase (SphK) inhibitors.
Gustin DJ; Li Y; Brown ML; Min X; Schmitt MJ; Wanska M; Wang X; Connors R; Johnstone S; Cardozo M; Cheng AC; Jeffries S; Franks B; Li S; Shen S; Wong M; Wesche H; Xu G; Carlson TJ; Plant M; Morgenstern K; Rex K; Schmitt J; Coxon A; Walker N; Kayser F; Wang Z
Bioorg Med Chem Lett; 2013 Aug; 23(16):4608-16. PubMed ID: 23845219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
